Matthew R Hellmann
age ~46
from Tampa, FL
- Also known as:
-
- Matthew Richard Hellmann
- Matt R Hellmann
- Mark Hellmann
- Phone and address:
-
2533 W Maryland Ave, Tampa, FL 33629
(813)2582264
Matthew Hellmann Phones & Addresses
- 2533 W Maryland Ave, Tampa, FL 33629 • (813)2582264
- Auburndale, FL
Work
-
Position:Tampa and st petersburg, florida area
Industries
Financial Services
Medicine Doctors
Matthew D. Hellmann
view sourceSpecialties:
Hematology/Oncology, Internal Medicine
Work:
Memorial Sloan Kettering Cancer Center
353 E 68 St, New York, NY 10065
(212)6392000 (phone), (212)9881079 (fax)
353 E 68 St, New York, NY 10065
(212)6392000 (phone), (212)9881079 (fax)
Education:
Medical School
Johns Hopkins University School of Medicine
Graduated: 2008
Johns Hopkins University School of Medicine
Graduated: 2008
Conditions:
Melanoma
Acute Renal Failure
Anemia
Atrial Fibrillation and Atrial Flutter
Hemorrhagic stroke
Acute Renal Failure
Anemia
Atrial Fibrillation and Atrial Flutter
Hemorrhagic stroke
Languages:
English
Description:
Dr. Hellmann graduated from the Johns Hopkins University School of Medicine in 2008. He works in New York, NY and specializes in Hematology/Oncology and Internal Medicine.
Resumes
Tampa And St Petersburg, Florida Area
view sourceLocation:
1410 north West Shore Blvd, Tampa, FL 33629
Industry:
Financial Services
Work:
Tampa and St Petersburg, Florida Area
Googleplus
Matthew Hellmann
News
Immune therapy scores big win against lung cancer in study
view source- The competitionDr. Matthew Hellmann of Memorial Sloan Kettering Cancer Center in New York led a study testing the Opdivo-Yervoy combo versus chemo in a slightly different group of newly diagnosed advanced lung cancer patients.
- Date: Apr 17, 2018
- Category: Health
- Source: Google
Merck drug results suggest it will extend its lead in lung cancer; Bristol-Myers shares drop
view source- "These practice-changing data establish the combination of nivolumab (Opdivo) plus ipilimumab (Yervoy) as a first-line treatment option for patients with high-TMB NSCLC," Dr. Matthew Hellmann, assistant attending at Memorial Sloan Kettering Cancer Center, said of the Bristol results.
- Date: Apr 16, 2018
- Category: Business
- Source: Google
Immune therapy scores big win against lung cancer in study
view source- Dr. Matthew Hellmann of Memorial Sloan Kettering Cancer Center in New York led a study testing the Opdivo-Yervoy combo versus chemo in a slightly different group of newly diagnosed advanced lung cancer patients.
- Date: Apr 16, 2018
- Category: Health
- Source: Google
Matthew Hellmann
view source
Matthew Hellmann
view source
Matthew Hellmann
view sourceMyspace
Youtube
Get Report for Matthew R Hellmann from Tampa, FL, age ~46